New drug combo targets rare, Tough-to-Treat cancer caused by prior therapy
Disease control
Ongoing
This study is testing whether two drugs, venetoclax and azacitidine, work better together to treat a specific type of bone marrow cancer called therapy-related myelodysplastic syndrome (t-MDS). This cancer can develop after a person has received chemotherapy or radiation for a pr…
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC